Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Atherosclerosis. 2012 Jul 25;224(2):506–510. doi: 10.1016/j.atherosclerosis.2012.07.024

Table 4.

Associations of baseline plaque with cognitive test scores at the 10-year follow-up examination.

Age-sex-education adjusted model Multivariable model
n Coef. se p n Coef. se p
TMT-A1 1210 1134
Plaque: 1–3 sites vs. 0 −0.19 1.76 0.92 −1.03 1.86 0.58
Plaque: 4–6 sites vs. 0 6.51 2.85 0.02 4.67 3.01 0.12
TMT-B2 1168 1133
Plaque: 1–3 sites vs. 0 4.71 3.68 0.20 0.88 3.84 0.82
Plaque: 4–6 sites vs. 0 12.82 6.06 0.03 7.81 6.31 0.22
DSST3 1188 1140
Plaque: 1–3 sites vs. 0 −0.60 0.63 0.34 0.18 0.65 0.78
Plaque: 4–6 sites vs. 0 −1.75 1.03 0.09 −0.50 1.07 0.64
AVLT4 1185 1110
Plaque: 1–3 sites vs. 0 0.02 0.42 0.97 0.27 0.44 0.54
Plaque: 4–6 sites vs. 0 0.38 0.68 0.58 0.92 0.71 0.20
VFT5 1223 1203
Plaque: 1–3 sites vs. 0 1.02 0.70 0.14 01.02 0.73 0.16
Plaque: 4–6 sites vs. 0 0.12 1.13 0.92 0.04 1.18 0.98

Multivariable models are further adjusted for

1

HDL cholesterol, hemoglobin A1C, SF-mental score, and antihypertensive medications;

2

antihypertensive medications, smoking, heavy drinking, BMI, SF-36 mental score;

3

antihypertensive medications, BMI, smoking, hemoglobin A1C, and SF-36 mental score;

4

antihypertensive medications, hemoglobin A1C, HDL cholesterol, BMI, NSAIDs, and SF-36 mental score;

5

antihypertensive medications, and smoking.